Search Results - "BERGSTRALH, E. J"

Glomerular filtration rate estimated by cystatin C among different clinical presentations by Rule, A.D., Bergstralh, E.J., Slezak, J.M., Bergert, J., Larson, T.S.

“…Glomerular filtration rate (GFR) estimates from serum creatinine has not been generalizable across all populations. Cystatin C has been proposed as an…”
Get full text

Transplantation Outcomes in Primary Hyperoxaluria by Bergstralh, E. J., Monico, C. G., Lieske, J. C., Herges, R. M., Langman, C. B., Hoppe, B., Milliner, D. S.

“…Optimal transplantation strategies are uncertain in primary hyperoxaluria (PH) due to potential for recurrent oxalosis. Outcomes of different transplantation…”
Get full text

Renal stone epidemiology in Rochester, Minnesota: An update by Lieske, J.C., Peña de la Vega, L.S., Slezak, J.M., Bergstralh, E.J., Leibson, C.L., Ho, K.-L., Gettman, M.T.

“…Studies in Western countries have suggested an increasing incidence of nephrolithiasis (NL) in the latter part of the 20th century. Therefore, we updated NL…”
Get full text

Sustained Pyridoxine Response in Primary Hyperoxaluria Type 1 Recipients of Kidney Alone Transplant by Lorenz, E. C., Lieske, J. C., Seide, B. M., Meek, A. M., Olson, J. B., Bergstralh, E. J., Milliner, D. S.

“…Combined liver kidney transplant is the preferred transplant option for most patients with primary hyperoxaluria type 1 (PH1) given that it removes the hepatic…”
Get full text

Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-up by Marcus, Pamela M., Bergstralh, Erik J., Fagerstrom, Richard M., Williams, David E., Fontana, Robert, Taylor, William F., Prorok, Philip C.

“…Background: The Mayo Lung Project (MLP) was a randomized, controlled clinical trial of lung cancer screening that was conducted in 9211 male smokers between…”
Get full text

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy by Ross, A E, Feng, F Y, Ghadessi, M, Erho, N, Crisan, A, Buerki, C, Sundi, D, Mitra, A P, Vergara, I A, Thompson, D J S, Triche, T J, Davicioni, E, Bergstralh, E J, Jenkins, R B, Karnes, R J, Schaeffer, E M

“…Background: Due to their varied outcomes, men with biochemical recurrence (BCR) following radical prostatectomy (RP) present a management dilemma. Here, we…”
Get full text

Clinical Significance of Alterations of Chromosome 8 in High-Grade, Advanced,Nonmetastatic Prostate Carcinoma by Sato, Kazunari, Qian, Junqi, Slezak, Jeffrey M., Lieber, Michael M., Bostwick, David G., Bergstralh, Erik J., Jenkins, Robert B.

“…BACKGROUND: Chromosome 8 alterations, including loss of 8p21-22 and gain of 8q24, are commonly observed in prostate carcinoma. We examined whether these…”
Get full text

Predicting renal outcome in IgA nephropathy by RADFORD, M. G, DONADIO, J. V, BERGSTRALH, E. J, GRANDE, J. P

“…Immunoglobulin A (IgA) nephropathy, the most common form of glomerulonephritis worldwide, is characterized by a heterogeneous clinical course. In this study,…”
Get full text

Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer by Zincke, H, Oesterling, J E, Blute, M L, Bergstralh, E J, Myers, R P, Barrett, D M

“…To provide information about long-term outcome after radical prostatectomy for clinically localized prostatic cancer (stage T2c or lower), we undertook a…”
Get more information

Use of tumor dynamics to clarify the observed variability among biochemical recurrence nomograms for prostate cancer by Dimonte, Guy, Bergstralh, E.J., Bolander, M.E., Karnes, R.J., Tindall, D.J.

“…BACKGROUND Nomograms for biochemical recurrence (BCR) of prostate cancer (PC) after radical prostatectomy can yield very different prognoses for individual…”
Get full text

Correlation of margin status and extraprostatic extension with progression of prostate carcinoma by Cheng, Liang, Darson, Michael F., Bergstralh, Erik J., Slezak, Jeff, Myers, Robert P., Bostwick, David G.

“…BACKGROUND The correlation of surgical margins and extraprostatic extension (EPE) with progression is uncertain with regard to prostate carcinoma patients…”
Get full text

Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades by Dinneen, S F, Valimaki, M J, Bergstralh, E J, Goellner, J R, Gorman, C A, Hay, I D

“…The present study was designed to define the factors that predict survival in patients with distant metastases (DM) from papillary thyroid carcinoma. We…”
Get more information

Preoperative Prediction of Surgical Margin Status in Patients With Prostate Cancer Treated by Radical Prostatectomy by LIANG CHENG, SLEZAK, J, BERGSTRALH, E. J, MYERS, R. P, ZINCKE, H, BOSTWICK, D. G

“…We sought to determine the preoperative factors associated with surgical margin status in patients who underwent radical prostatectomy for prostate cancer. The…”
Get full text

Comparison of self-reported and medical record health care utilization measures by Roberts, Rosebud O., Bergstralh, Erik J., Schmidt, Luanne, Jacobsen, Steven J.

“…Self-reported utilization of health care services is important in epidemiological studies and in health care planning, policy, and research, and the accuracy…”
Get full text

Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? by Amling, C L, Bergstralh, E J, Blute, M L, Slezak, J M, Zincke, H

“…The most appropriate definition of biochemical progression after radical prostatectomy and radiation therapy is uncertain. We analyzed the effect of using…”
Get more information

Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy by BLUTE, M. L, BOSTWICK, D. G, BERGSTRALH, E. J, SLEZAK, J. M, MARTIN, S. K, AMLING, C. L, ZINCKE, H

“…The impact of a positive surgical margin in otherwise confined prostate cancer after radical prostatectomy remains unclear. We analyzed the outcome of a large…”
Get full text

Somatostatin analog therapy for severe polycystic liver disease: results after 2 years by HOGAN, Marie C, MASYUK, Tetyana V, LARUSSO, Nicholas F, TORRES, Vicente E, PAGE, Linda, HOLMES, David R, XUJIAN LI, BERGSTRALH, Eric J, IRAZABAL, Maria V, KIM, Bohyun, KING, Bernard F, GLOCKNER, James F

“…We showed in a randomized double-blinded placebo-controlled clinical trial that octreotide long-acting repeatable depot.® (OctLAR(®)) for 12 months reduces…”
Get full text

Incidence of physician‐diagnosed interstitial cystitis in Olmsted County: a community‐based study by Roberts, R.O., Bergstralh, E.J., Bass, S.E., Lightner, D.J., Lieber, M.M., Jacobsen, S.J.

“…OBJECTIVE To obtain community‐based information about the incidence of interstitial cystitis, a chronic disabling condition of the bladder where knowledge is…”
Get full text

Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease by O'Sullivan, DA, Torres, VE, Gabow, PA, Thibodeau, SN, King, BF, Bergstralh, EJ

“…Recent experiments in cultured cyst epithelial cells from kidneys of patients with autosomal dominant polycystic kidney disease (ADPKD) have shown that the…”
Get full text

Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota by Roberts, R O, Bergstralh, E J, Katusic, S K, Lieber, M M, Jacobsen, S J

“…We describe trends in prostate cancer mortality from 1980 to 1997, before and after the introduction of serum prostate specific antigen (PSA) testing to the…”
Get more information